ArticleScientific reports2022

Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis.

Yuichi Chikata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.